Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» gilteritinib
gilteritinib
Astellas' AML drug wins over CHMP — strengthening lead on Daiichi Sankyo
Astellas' AML drug wins over CHMP — strengthening lead on Daiichi Sankyo
Endpoints
Astellas
FDA
gilteritinib
Europe
AML
Daiichi Sankyo
Flag link:
FDA stamps fast OK on Astellas' pioneering FLT3 AML drug gilteritinib, expanding on a record year for new approvals
FDA stamps fast OK on Astellas' pioneering FLT3 AML drug gilteritinib, expanding on a record year for new approvals
Endpoints
Astellas
FDA
AML
Xospata
gilteritinib
Flag link:
